1888 PressRelease - The Platinum Capital Group, the Hong Kong based boutique Investment Firm in the Private Equity market, today confirmed the firm's attendence at the 9th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology in Lisbon next year.
The show, which will take place on the 31 March to the 3 April, 2014 at the Sana Lisboa Hotel in central Lisbon, is one of the most attended bio-tech conferences on the calendar, and covers and number of hot and current life science and bio-technology topics such as nanomaterials and nanotechnologies, personalized medicines and theragnostics and advanced therapy medicinal products.
The conference, now in its twelfth year, provides a neutral forum where investors, industry analysts, doctors and senior biotechnology executives have the opportunity to shape the future investment landscape of the life science and bio-technology industry.
"The bio-tech and life science industry continues to generate shareholder value and participating these conferences only goes to further enhance exposure and opportunity for Platinum Capital and our clients," said Mr. Larrs Mueller, Director of Retail Trading.
About The Platinum Capital Group
The Platinum Capital Group is a privately owned, boutique Investment Firm in the Private Equity market. The Platinum Capital Group has a number of centres of excellence but most importantly, works with companies in the Health Sector, both with care and management companies, plus Bio-technology and medical device manufacturers. The Platinum Capital Group has lead or managed over fifty Private Equity and Venture Capital investment projects across Asia and beyond. Examples of these have been in the areas of 3D printing of human tissue and abnormality testing within the human gene pool.
Two Exchange Square
Central, Hong Kong
Tel. +(852) 5808 6128